Skip to content

Where is the Best Place to Inject Octreotide? A Guide to Sites

4 min read

Octreotide is used to treat acromegaly and symptoms from neuroendocrine tumors, with studies showing it can significantly increase time to tumor progression [1.8.1]. Understanding where is the best place to inject octreotide is crucial for effective treatment and minimizing discomfort.

Quick Summary

This overview details the recommended injection sites for both short-acting (subcutaneous) and long-acting (intramuscular) octreotide, emphasizing the importance of site rotation for patient comfort and medication efficacy.

Key Points

  • Two Formulations, Two Sites: Short-acting octreotide is injected subcutaneously (under the skin) in the abdomen, thigh, or arm, while long-acting (LAR) is injected intramuscularly into the gluteal muscle (buttocks) [1.2.6, 1.4.4].

  • Subcutaneous Sites: The best places for daily, short-acting injections are the fatty parts of the skin on the abdomen, thighs, and upper arms [1.2.1].

  • Intramuscular (LAR) Site: The long-acting depot formulation must be injected deep into the gluteal muscle by a healthcare professional [1.4.5, 1.4.4].

  • Rotation is Crucial: For both types of injections, it is essential to rotate the injection site to avoid skin irritation, pain, and tissue buildup [1.5.1, 1.5.6].

  • Avoid the Deltoid: For long-acting (LAR) injections, the deltoid (shoulder) muscle should be avoided due to significant pain and discomfort at the site [1.5.6].

  • Preparation Reduces Pain: Allowing the medication to reach room temperature before a subcutaneous injection can help reduce pain at the injection site [1.5.2].

  • Professional Administration for LAR: Sandostatin LAR Depot injections must be prepared and administered by a trained healthcare professional [1.4.3].

In This Article

Understanding Octreotide and Its Formulations

Octreotide is a synthetic hormone medication used to treat several conditions, primarily acromegaly and the symptoms associated with certain neuroendocrine tumors (NETs), like carcinoid tumors and vasoactive intestinal peptide-secreting tumors (VIPomas) [1.6.4, 1.6.3]. It works by mimicking the natural hormone somatostatin, which helps to inhibit the release of other hormones, such as growth hormone [1.6.2]. This action helps control symptoms like severe diarrhea and flushing [1.6.4]. The medication comes in two main forms, and the administration site depends entirely on which type you are using [1.2.6].

  • Short-Acting Octreotide (Subcutaneous): This version is typically self-administered two to four times a day via an injection into the fatty tissue just under the skin (subcutaneously) [1.3.4, 1.6.2].
  • Long-Acting Release (LAR) Depot (Intramuscular): Known by brand names like Sandostatin® LAR Depot, this formulation is a slow-release version given as a deep intramuscular injection, usually once every four weeks by a healthcare provider [1.4.5, 1.4.2].

Where is the Best Place to Inject Octreotide? Subcutaneous (Short-Acting)

For the immediate-release, subcutaneous injections that are taken multiple times a day, the goal is to inject into the fatty part of the skin. Patients are often taught by a nurse or doctor how to perform these injections at home [1.2.1].

Recommended Subcutaneous Injection Sites:

  • Abdomen (Belly): This is a common and easily accessible site. You should avoid the area immediately around the belly button (navel), maintaining at least a two-inch distance [1.2.1, 1.3.1].
  • Thighs: The top and outer parts of the thighs are suitable locations [1.2.1, 1.3.1].
  • Upper Arms: The outer area of the upper arm can be used, particularly if someone else is administering the injection for you [1.2.1, 1.2.2].
  • Buttocks: The outer part of the buttocks is another option [1.2.2].

The Critical Role of Site Rotation

It is essential to rotate injection sites with every dose [1.2.1]. Consistently using the same spot can lead to skin injury, irritation, pain, or a build-up of fatty tissue, which can affect how the medication is absorbed [1.3.2, 1.5.4]. A good practice is to avoid injecting within two inches of your last injection site [1.2.1]. Keeping a simple chart or log of your injection sites can help you remember to rotate them effectively. For example, you might use the abdomen for one injection and the thigh for the next [1.2.2].

Where is the Best Place to Inject Octreotide? Intramuscular (Long-Acting)

The long-acting release (LAR) depot version of octreotide must be administered by a trained healthcare professional [1.4.3]. This is because it requires a deep intramuscular injection for the medication to be released slowly and consistently over four weeks [1.4.2].

Recommended Intramuscular Injection Site:

  • Gluteal Muscle (Buttocks): The primary and recommended site for Sandostatin LAR Depot is the gluteal muscle [1.4.4, 1.4.7]. The injection is given deep into the muscle of the buttock.

Site Rotation for LAR Injections

Even with these monthly injections, rotation is key. The site of the intragluteal injection should be alternated between the left and right gluteal muscle with each administration [1.4.3]. This systematic rotation helps to avoid irritation [1.5.6]. It is specifically recommended to avoid using the deltoid (shoulder) muscle for LAR injections, as this can cause significant discomfort at the site [1.5.6].

Injection Site Comparison

Feature Subcutaneous (Short-Acting) Intramuscular (Long-Acting/LAR)
Who Injects? Patient or caregiver at home [1.2.1] Healthcare provider in a clinical setting [1.4.5]
Primary Sites Abdomen, thighs, upper arms [1.2.1, 1.2.2] Gluteal muscle (buttocks) [1.4.4]
Frequency 2 to 4 times per day [1.3.4] Once every 4 weeks [1.4.7]
Rotation Rotate with every injection [1.2.1] Alternate between left and right gluteal muscle monthly [1.4.3]
Key Consideration Avoid area near belly button; let medicine warm to room temp to reduce pain [1.2.1, 1.5.2] Must be a deep muscle injection; avoid deltoid muscle [1.5.6]

Pre-Injection and Post-Injection Best Practices

To ensure safety and minimize side effects like pain at the injection site, follow these general steps:

  1. Preparation: Always wash your hands before and after [1.2.1]. For subcutaneous injections, allow the medication to come to room temperature before injecting, as cold medicine can cause more discomfort [1.5.2]. Do not heat it [1.2.1].
  2. Cleaning: Clean the chosen injection site with an alcohol wipe and let it air dry completely before the injection [1.2.2].
  3. Administration: For subcutaneous shots, pinch the skin and insert the needle at a 90-degree angle [1.3.1]. Push the plunger to inject all the contents, then withdraw the needle.
  4. Disposal: Immediately dispose of used needles and syringes in a designated sharps container [1.2.1].

Conclusion

Ultimately, where is the best place to inject octreotide depends entirely on whether you are using the short-acting subcutaneous or the long-acting intramuscular (LAR) formulation. For daily subcutaneous injections, the abdomen and thighs are preferred sites, with a strict rotation policy to prevent skin issues [1.2.1, 1.3.1]. For the monthly LAR version, the only recommended site is the gluteal muscle, administered by a healthcare professional, alternating between the left and right side each month [1.4.4, 1.5.6]. Adhering to these guidelines and the instructions from your healthcare provider is the best way to ensure effective treatment and minimize discomfort.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for guidance on your specific medical condition and treatment. For detailed instructions on administration, refer to the manufacturer's patient information or a healthcare provider.

Novartis - Sandostatin LAR Depot Administration Guide

Frequently Asked Questions

Subcutaneous (short-acting) octreotide is injected into the fatty tissue under the skin 2-4 times a day, while intramuscular (long-acting or LAR) is injected deep into the gluteal muscle once every 4 weeks by a healthcare provider [1.3.4, 1.4.7].

No, Sandostatin LAR Depot must be administered by a trained healthcare professional as it requires a specific technique for deep intramuscular injection into the gluteal muscle [1.4.5, 1.4.3].

Rotating injection sites helps to avoid skin injury, irritation, pain, and the buildup of fatty tissue, which can interfere with how the medication is absorbed [1.5.1, 1.5.4, 1.3.2].

The recommended sites for subcutaneous (short-acting) octreotide are the fatty parts of the abdomen (avoiding the belly button), the top of the thighs, and the outer area of the upper arms [1.2.1, 1.3.1].

Sandostatin LAR should only be injected into the gluteal muscle (buttock). The injection site should be alternated between the left and right buttock with each monthly dose [1.4.4].

Injecting into the same spot repeatedly can cause local skin reactions, pain, and a buildup of tissue under the skin that may reduce the medication's effectiveness [1.5.1, 1.5.2].

For subcutaneous injections, allowing the medication to warm to room temperature before injecting can reduce pain. Also, be sure to rotate sites with every injection [1.5.2]. Pain at the site is a common side effect but typically subsides quickly [1.7.5].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.